Skip Navigation
Skip to contents

Ann Lab Med.  2016 Mar;36(2):85-100. 10.3343/alm.2016.36.2.85.

Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways

Affiliations
  • 1Institute of Pharmaceutical Biology/DCAL, Goethe-University of Frankfurt, Biocenter, Frankfurt/Main, Germany. Rolf.Marschalek@em.uni-frankfurt.de

Abstract

Chromosomal translocations of the human mixed-lineage leukemia (MLL) gene have been analyzed for more than 20 yr at the molecular level. So far, we have collected about 80 direct MLL fusions (MLL-X alleles) and about 120 reciprocal MLL fusions (X-MLL alleles). The reason for the higher amount of reciprocal MLL fusions is that the excess is caused by 3-way translocations with known direct fusion partners. This review is aiming to propose a solution for an obvious problem, namely why so many and completely different MLL fusion alleles are always leading to the same leukemia phenotypes (ALL, AML, or MLL). This review is aiming to explain the molecular consequences of MLL translocations, and secondly, the contribution of the different fusion partners. A new hypothesis will be posed that can be used for future research, aiming to find new avenues for the treatment of this particular leukemia entity.

Keyword

MLL-r leukemia; Translocation partner genes; Molecular mechanisms of cancer

MeSH Terms

Alleles
Chromosomes, Human, X
Epigenesis, Genetic
Humans
Leukemia/classification/*genetics/pathology
Myeloid-Lymphoid Leukemia Protein/chemistry/genetics
Protein Structure, Tertiary
Translocation, Genetic
Myeloid-Lymphoid Leukemia Protein
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr